RxDoctor Payments Data

Jonathan Sembrano, MD

Orthopaedic Surgery · Minneapolis, MNNPI 1932113487

Payments from drug & device makers

What this record shows

10 manufacturers reported payments, led by Si-bone, Inc. at 45.2% of the total. 2025 is the largest year on record at $3,291, more than ten times the $81 reported in 2019.

$5,498in general payments, 2019–2025

Across 41 payments — averaging $134.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Si-bone, Inc.$2K
  • Smaio SA$914
  • Medtronic$790
  • Smaio USA Corporation$416
  • Globus Medical$409
  • Alphatec Spine, Inc$192
  • plus $292 from 4 others
$346,510in research payments, 2019–2025

Across 29 payments — averaging $11,949 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$228K
  • Globus Medical$100K
  • Orthofix Medical, Inc.$19K

What the payments were for

  • Travel & lodging$2,40144%
  • Food & beverage$3,09756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Si-bone, Inc.8$2,485
Smaio SA5$914
Medtronic(2 entities)13$790
Smaio USA Corporation2$416
Globus Medical5$409
Alphatec Spine, Inc2$192
Kuros Biosciences USA, Inc1$127
Kerecis Limited2$112
Orthofix Medical, Inc.2$28
Johnson & Johnson1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,498 in reported general payments places this provider in the 55th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$126,055
Medicare patients
108
Services billed
388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methocarbamol34$334
Gabapentin21$301
Methylprednisolone20$166
Cyclobenzaprine Hcl23$93
Hydroxyzine Hcl15$69

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →